Literature DB >> 30230601

Interaction of long noncoding RNA MEG3 with miRNAs: A reciprocal regulation.

Mohammad-Taher Moradi1, Hossein Fallahi1,2, Zohreh Rahimi1,3.   

Abstract

The competitive endogenous RNA (ceRNA) hypothesis suggests that a long noncoding RNA (lncRNA) can function as sinks for pools of microRNAs (miRNAs); thereby, in the presence of ceRNA, messenger RNAs (mRNAs) targeted by specific miRNAs can liberate and translate to protein. Maternally expressed gene 3 (MEG3) is a lncRNA, which its expression has been detected in various normal tissues, while it is lost or downregulated in human tumors. The MEG3 is an imprinted gene which, is methylated and suppressed by DNA methyltransferases (DNMTs) family. Also, miRNAs are involved in the regulation of MEG3 gene expression. Interestingly, the lncRNA MEG3 (lnc-MEG3), as a ceRNA affects various cell processes such as proliferation, apoptosis, and angiogenesis by sponging miRNAs. These miRNAs, in turn, regulate different mRNAs in different pathways. This review focuses on the interaction between lnc-MEG3 and experimentally validated miRNAs. In addition, the discussion supplemented by some data obtained from mirPath (v.3) and TarBase (v.8) databanks to provide more details about the pathways affected by this ceRNA.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  DNA methyltransferases; competitive endogenous RNA; long noncoding RNA MEG3; microRNAs

Year:  2018        PMID: 30230601     DOI: 10.1002/jcb.27604

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  11 in total

Review 1.  Maternally expressed gene 3 in metabolic programming.

Authors:  Samuel Hamilton; Rafael de Cabo; Michel Bernier
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-07-01       Impact factor: 4.490

2.  Dysregulation of long noncoding RNA MEG3 and NLRC5 expressions in patients with relapsing-remitting multiple sclerosis: is there any correlation?

Authors:  Shahram Torkamandi; Shima Bahrami; Tahereh Ghorashi; Mohammad Dehani; Hadi Bayat; Seyyed Mohamad Hoseini; Somaye Rezaei; Mohsen Soosanabadi
Journal:  Genes Immun       Date:  2021-11-15       Impact factor: 2.676

3.  Integrated Analysis of Angiogenesis Related lncRNA-miRNA-mRNA in Patients With Coronary Chronic Total Occlusion Disease.

Authors:  Wei Gao; Jianhui Zhang; Runda Wu; Jie Yuan; Junbo Ge
Journal:  Front Genet       Date:  2022-04-25       Impact factor: 4.772

4.  Transcriptome and chromatin alterations in social fear indicate association of MEG3 with successful extinction of fear.

Authors:  Melanie Royer; Balagopal Pai; Rohit Menon; Anna Bludau; Katharina Gryksa; Rotem Ben-Tov Perry; Igor Ulitsky; Gunter Meister; Inga D Neumann
Journal:  Mol Psychiatry       Date:  2022-03-25       Impact factor: 13.437

5.  hnRNPK-regulated LINC00263 promotes malignant phenotypes through miR-147a/CAPN2.

Authors:  Woo Joo Lee; Chang Hoon Shin; Haein Ji; Seong Dong Jeong; Mi-So Park; Hong-Hee Won; Poonam R Pandey; Dimitrios Tsitsipatis; Myriam Gorospe; Hyeon Ho Kim
Journal:  Cell Death Dis       Date:  2021-03-17       Impact factor: 8.469

Review 6.  Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities?

Authors:  Folake Orafidiya; Lin Deng; Charlotte Lynne Bevan; Claire Emily Fletcher
Journal:  Cancers (Basel)       Date:  2022-01-31       Impact factor: 6.639

7.  Long Non-coding RNA MEG3 Promotes Pyroptosis in Testicular Ischemia-Reperfusion Injury by Targeting MiR-29a to Modulate PTEN Expression.

Authors:  Jin-Zhuo Ning; Kai-Xiang He; Fan Cheng; Wei Li; Wei-Min Yu; Hao-Yong Li; Ting Rao; Yuan Ruan
Journal:  Front Cell Dev Biol       Date:  2021-06-18

Review 8.  Long non-coding RNAs regulating multiple proliferative pathways in cancer cell.

Authors:  Marco De Martino; Francesco Esposito; Pierlorenzo Pallante
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

9.  LncRNA MEG3 inhibits the development of nasopharyngeal carcinoma by sponging miR-543 targeting KLF4.

Authors:  Jiayu Ning; Liqin Zhang; Hua Guo; Sujuan Zhou; Xiaomei Sun; Weijing Bao
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

Review 10.  LncRNA: A Potential Target for Host-Directed Therapy of Candida Infection.

Authors:  Ye Wang; Hongdan Xu; Na Chen; Jin Yang; Hongmei Zhou
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.